Richard Hartnell – Psychedelic Science (MAPS) 2017 Interview

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Don Lattin – Psychedelic Science (MAPS) 2017 Interview

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Mike Crowley – Psychedelic Science (MAPS) 2017 Interview

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico – Thomas Kingsley Brown

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



http://psychedelicscience.org

Help us caption and translate this video on Amara.org:‪ ‬http://www.amara.org/en/videos/ypBoaytF37qb/info/

Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico

Thomas Kingsley Brown, PhD

This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at ...

Continue Reading →

Notes on Progress in the New Zealand Ibogaine Study – Geoff Noller

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



http://psychedelicscience.org

Help us caption and translate this video on Amara.org:‪ ‬http://www.amara.org/en/videos/w5HzSJBjBSdf/info/

Notes on Progress in the New Zealand Ibogaine Study

Geoff Noller, PhD

This presentation reports on the first year of progress in the New Zealand observational study of ibogaine treatment outcomes for opioid-dependent persons. Current participants’ data are reviewed and the implications of New Zealand’s ibogaine legislation for research and treatment are discussed.

Dr. Geoff Noller has a background in ...

Continue Reading →
UA-77446339-1